SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:gup.ub.gu.se/317073"
 

Sökning: onr:"swepub:oai:gup.ub.gu.se/317073" > Epidemiology, Survi...

Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis

Lindgren, Ulrika (författare)
Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för laboratoriemedicin,Department of Laboratory Medicine
Pullerits, Rille, 1969 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för reumatologi och inflammationsforskning,Institute of Medicine, Department of Rheumatology and Inflammation Research
Lindberg, C. (författare)
visa fler...
Oldfors, Anders, 1951 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för laboratoriemedicin,Department of Laboratory Medicine
visa färre...
 (creator_code:org_t)
2022-06-06
2022
Engelska.
Ingår i: Annals of Neurology. - : Wiley. - 0364-5134 .- 1531-8249. ; 92:2, s. 201-212
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Objective We performed a population-based study on inclusion body myositis with the primary aims to define the prevalence, survival rate, and incidence, and to investigate the symptom profiles associated with disease duration and sex over a 33-year period. Methods Patients diagnosed between 1985 and 2017 in Region Vastra Gotaland, Sweden, were identified according to the European Neuromuscular Centre diagnostic criteria from 2011. Results We identified 128 patients, 89 men and 39 women, with the strict clinicopathological definition of inclusion body myositis. The prevalence was 32 per million inhabitants, 19 per million women and 45 per million men, by December 31, 2017. Mean incidence was 2.5 per million inhabitants and year. Mean age at symptom onset was 64.4 years with quadriceps weakness being the most common presenting symptom followed by finger flexor weakness. Dysphagia was a common presenting symptom being more frequent in women (23%) than men (10%) and was during the disease course reported in 74% of men and 84% of women. Seventy-three patients were deceased, with a mean survival of 14 years from symptom onset. Survival rates from both diagnosis date and symptom onset were decreased compared to the matched population. Twenty-one percent of the patients had an additional autoimmune disease. A cross-sectional analysis of autoantibodies in 50 patients and 28 matched controls showed autoantibodies to cytosolic 5 '-nucleotidase 1A in 40% of the patients and 3.6% of controls. Interpretation Inclusion body myositis is an autoimmune disease with decreased survival rate and with marked sex differences in both prevalence and clinical manifestations. ANN NEUROL 2022

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)

Nyckelord

cytosolic 5'-nucleotidase 1a
inflammatory myopathy
disease
prevalence
dysphagia
antibody
autoantibodies
management
features
Neurosciences & Neurology

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...
Lindgren, Ulrika
Pullerits, Rille ...
Lindberg, C.
Oldfors, Anders, ...
Om ämnet
MEDICIN OCH HÄLSOVETENSKAP
MEDICIN OCH HÄLS ...
och Klinisk medicin
och Neurologi
Artiklar i publikationen
Annals of Neurol ...
Av lärosätet
Göteborgs universitet

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy